The immunogenicity and safety of a single 0.5 mL dose of virosomal subunit influenza vaccine administered to unprimed children aged ≥6 to <36 months: Data from a randomized, Phase III study
Keywords: ویروسومال; Influenza; Virosomal; Children; Vaccination schedule; Immunogenicity